Clearmind Biomedical Inc.
Update：2025/12/03
Industries
Main Industry
Health Care
Main Product/Service
1. Axonpen System
2. Neuroblade System
3. Clearpath
2. Neuroblade System
3. Clearpath
Founded Year
2019
Unified Business No.
82827535
Status
Active
Number of Employees
0
Total Paid-in
Capital
190,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Our proprietary micro-invasive technology can safely remove the brain hemorrhage and more patients can survive and recovery better. In addition, our technology decreases the operation time, blood loss, and the wound length. The problem with most minimally invasive surgery is that it is hard to learn, there is technical barrier that may make the surgery difficult even for the experienced surgeons, and that it can only be applied in medical centers. Since more evidence in the literature suggest the minimally invasive surgery do help patients, neurosurgeons worldwide has been interested in adopting this technique, but we know it is not easy. That's why we want to make it a device - a device as solution, that is easy to use and help more neurosurgeons saves lives also improve patient outcome. We know we can help more patients!
